Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
163 studies found for:    "Sarcoidosis"
Show Display Options
Rank Status Study
1 Withdrawn Cardiac Sarcoidosis Response To Steroids Trial
Conditions: Cardiac Sarcoidosis;   Sarcoidosis
Intervention: Drug: Prednisone
2 Completed Cardiac Sarcoidosis: FDG PET vs. Ga-DOTANOC PET
Conditions: Sarcoidosis;   Cardiac Sarcoidosis
Intervention:
3 Recruiting Acthar Gel for Chronic Pulmonary Sarcoidosis (ACPS)
Conditions: Sarcoidosis;   Pulmonary Sarcoidosis
Intervention: Drug: Acthar gel
4 Not yet recruiting ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study
Conditions: Sarcoidosis;   Hypercalcemia Due to Sarcoidosis
Intervention: Drug: ACTHAR Gel (adrenocorticotropic hormone)
5 Terminated Safety of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Adults With Stage II or III Pulmonary Sarcoidosis
Conditions: Stage 2 Pulmonary Sarcoidosis;   Stage 3 Pulmonary Sarcoidosis
Intervention: Biological: PDA001 (cenplacel-L)
6 Suspended Stromal Gene Expression During Pulmonary Sarcoidosis
Condition: Sarcoidosis
Intervention:
7 Completed
Has Results
Atorvastatin to Treat Pulmonary Sarcoidosis
Condition: Sarcoidosis, Pulmonary
Intervention: Drug: Atorvastatin
8 Recruiting Worldwide Sarcoidosis Research Study
Condition: Sarcoidosis
Intervention:
9 Not yet recruiting ACTHAR Gel for Cutaneous Sarcoidosis: An Open Label Trial
Conditions: Sarcoidosis;   Cutaneous Sarcoidosis
Interventions: Drug: ACTHAR Gel 40 units twice weekly;   Drug: ACTHAR Gel 80 units twice weekly.
10 Completed Rituximab for Pulmonary Sarcoidosis
Condition: Sarcoidosis
Intervention: Drug: Rituximab
11 Completed The Efficacy and Safety of CC-10004 in Chronic Cutaneous Sarcoidosis
Conditions: Sarcoidosis;   Cutaneous Sarcoidosis
Intervention: Drug: CC-100004
12 Withdrawn Efficacy Study of Humira in the Treatment of Cutaneous Sarcoidosis
Conditions: Sarcoidosis;   Cutaneous Sarcoidosis
Intervention: Drug: Humira
13 Not yet recruiting Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Patients With Pulmonary Sarcoidosis
Condition: Pulmonary Sarcoidosis
Interventions: Drug: ACZ885;   Drug: Placebo
14 Completed Treatment of Pulmonary Sarcoidosis With Pentoxifylline
Condition: Pulmonary Sarcoidosis
Intervention: Drug: Pentoxifylline
15 Withdrawn A Phase 2 Study With CC-220 in Skin Sarcoidosis
Condition: Sarcoidosis
Interventions: Drug: CC-220 0.3 mg Daily;   Drug: CC-220 0.6mg Daily;   Drug: Placebo
16 Completed Eye and Immunogenetic Features of Sarcoidosis
Conditions: Sarcoidosis;   Uveitis
Intervention:
17 Recruiting Riociguat for Sarcoidosis Associated Pulmonary Hypertension
Condition: Sarcoidosis
Interventions: Drug: Riociguat;   Drug: Placebo
18 Completed
Has Results
Investigation of the Efficacy of Antibiotics on Pulmonary Sarcoidosis
Conditions: Pulmonary Sarcoidosis;   Lung Function
Intervention: Drug: levaquin; ethambutol; rifampin and azithromycin.
19 Completed Study of Eye Tissue for Sarcoidosis
Condition: Sarcoidosis
Intervention:
20 Completed Antibody Response to Influenza Vaccine in Patients With Sarcoidosis
Condition: Pulmonary Sarcoidosis
Intervention: Biological: Influenza Vaccine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years